Can self-administered questionnaires supplant objective testing of erectile function? A comparison between the international index of erectile function and objective studies

International Journal of Impotence Research

Volumn 18, Issue 2, 2006, Pages 126-129

  Melman, A ^a   Fogarty, J ^a   Hafron, J ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

ED evaluation; Erectile dysfunction; IIEF; NPT; Rigiscan

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ERECTILE DYSFUNCTION; HUMAN; MALE; MEDICAL INSTRUMENTATION; PENIS NOCTURNAL TUMESCENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SELF REPORT; UROLOGY;

ADULT; DIABETES COMPLICATIONS; HUMANS; HYPERTENSION; IMPOTENCE; MALE; MIDDLE AGED; PENILE ERECTION; PHYSICAL EXAMINATION; QUESTIONNAIRES;

EID: 33644763851     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901361     Document Type: Article

References (26)

1. Fineman KR, Rettinger HI. Development of the male function profile/impotence questionnaire. Psychol Rep 1991; 68: 1151-1175.
2. Geisser ME, Murray FT, Cohen MS, Shea PJ, Addeo RR. Use of the Florida Sexual History Questionnaire to differentiate primary organic from primary psychogenic impotence. J Androl 1993; 14: 298-303.
3. Speckens AE, Hengeveld MW, Lycklama a Nijeholt GA, van Hemert AM, Hawton KE. Discrimination between psychogenic and organic erectile dysfunction. J Psychosom Res 1993; 37: 135-145.
4. Padma-Nathan H, Steers WD, Wicker PA. Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: a double-blind, placebo-controlled study of 329 patients. Sildenafil Study Group. Int J Clin Pract 1998; 52: 375-379.
5. Brock GB, McMahon CG, Chen KK, Costigan T, Shen W, Watkins V et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol 2002; 168: 1332-1336.
6. Hellstrom WJ, Gittelman M, Karlin G, Segerson T, Thibonnier M, Taylor T et al. Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial. J Androl 2002; 23: 763-771.
7. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. New Engl J Med 1998; 338: 1397-1404.
8. Blander DS, Sanchez-Ortiz RF, Broderick GA. Sex inventories: can questionnaires replace erectile dysfunction testing? Urology 1999; 54: 719-723.
9. Corty EW, Althof SE, Kurit DM. The reliability and validity of a sexual functioning questionnaire. J Sex Marital Ther 1996; 22: 27-34.
10. Ponhorzer A, Temml C, Mock K, Marszlaek M, Obermayer R, Madersbacher S. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol 2005; 47: 80-86.
11. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile function domain on the International Index of Erectile Function. Urology 1999; 54: 346-351.
12. Kassouf W, Carrier S. A comparison of the International Index of Erectile Function and erectile dysfunction studies. BJU Int 2003; 91: 667-669.
13. Melman A, Tiefer L, Pedersen R. Evaluation of the first 406 patients in a urology department based center for male sexual dysfunction. Urology 1988; 32: 6-10.
14. Dow JA, Gluck RW, Golimbu M, Weinberg GI, Morales P. Multiphasic diagnostic evaluation of arteriogenic, venogenic, and sinusoidogenic impotency. Value of noninvasive tests compared with penile duplex ultrasonography. Urology 1991; 38: 402-407.
15. Bleustein CB, Eckholdt H, Arezzo JC, Melman A. Quantitative somatosensory testing of the penis: optimizing the clinical neurological examination. J Urol 2003; 169: 2266-2269.
16. Bleustein CB, Arezzo JC, Eckholdt H, Melman A. The neuropathy of erectile dysfunction. Int J Impot Res 2002; 14: 433-439.
17. Benet AE, Rehman J, Holcomb RG, Melman A. The correlation between the new RigiScan plus software and the final diagnosis in the evaluation of erectile dysfunction. J Urol 1996; 156: 1947-1950.
18. Davis-Joseph B, Tiefer L, Melman A. Accuracy of the initial history and physical examination to establish the etiology of erectile dysfunction. Urology 1995; 45: 498-502.
19. Licht MR, Lewis RW, Wollan PC, Harris CD. Comparison of Rigiscan and sleep laboratory nocturnal penile tumescence in the diagnosis of organic impotence. J Urol 1995; 154: 1740-1743.
20. Ogrinc FG, Linet OI. Evaluation of real-time Rigiscan monitoring in pharmacological erection. J Urol 1995; 154: 1356-1359.
21. Blander DS, Sanchez-Ortiz RF, Broderick GA. Sex inventories: can questionnaires replace erectile dysfunction testing? Urology 1999; 54: 719-723.
22. Rosen RC, Cappelleri JC, Gendrano III N. The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res 2002; 14: 226-244.
23. Padma-Nathan H. Diagnostic and treatment strategies for erectile dysfunction: the 'Process of Care' model. [University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School]. Int J Impot Res 2000; 12(Suppl 4): S119-S121.
24. Christ GJ. Gene therapy treatments for erectile and bladder dysfunction. Curr Urol Rep 2004; 5: 52-60.
25. Melman A, Zhao W, Davies KP, Bakal R, Christ GJ. The successful long-term treatment of age related erectile dysfunction with hSlo cDNA in rats in vivo. J Urol 2003; 170: 285-290.
26. Melman A, Bar-Chama N, McCullough A, Davies K, Christ G. The first human trial for gene transfer therapy for the treatment of erectile dysfunction: preliminary results. Eur Urol 2005; 48: 314-318.